Answers are grounded in this paper and cite their sources.
Cross-sectional survey investigates HIV prevalence and injection behaviors in Nigeria, indicating significant risks.
Introduction: People who inject drugs (PWID) are an important driver of the HIV epidemic in Nigeria. This study describes the HIV, demographic, and injection characteristics of PWID. Methods: Cross-sectional integrated biological and behavioural survey conducted in 2020 across 12 states in Nigeria. HIV seroprevalence based on screening and confirmatory tests, and self-reported data on socio-demographic and injection/sharing practices. Multivariable logistic regression models estimated crude and adjusted odds ratios (A/ORs) and 95% confidence intervals (95% CIs) of factors associated with HIV prevalence, and injection and sharing practices. Results: Among 4,358 participants, weighted HIV prevalence was 10.9%. Median age was 30 years (IQR: 25-35) with two-thirds reporting less than 75 months of injection drug use. 80% of participants reported injecting in the last month. Of those injecting in the last month, 21% reported injecting at least once a day, 15% reported “almost/every time” to sharing or lending syringes/needles, while 9% reported back/front-loading, sharing paraphernalia, or drawing up from a common container “almost/every time”. In multivariable models, female sex (AOR: 1.6, 95% CI: 1.2-2.1) and less than secondary education (AOR: 1.4, 95% CI: 1.1-2.0) was associated with HIV. Riskier injection practices were associated with pentazocine (AOR: 1.7, 95% CI: 1.2-2.4) and crack cocaine (AOR: 2.0, 95% CI: 1.4-2.8) injection. Conclusions: HIV prevalence was high amongst study participants, as were riskier injection and sharing practices, with structural determinants like education being associated with both.
No takes yet. Share an insight, caveat, or question.
Shaw et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: